标题
Optimal Management of Cancer Treatment-Induced Bone Loss
作者
关键词
-
出版物
DRUGS & AGING
Volume 28, Issue 11, Pages 867-883
出版商
Springer Nature
发表日期
2011-10-29
DOI
10.2165/11595820-000000000-00000
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Aromatase inhibitors, efficacy and metabolic risk in the treatment of postmenopausal women with early breast cancer
- (2016) Stefano Gonnelli Clinical Interventions in Aging
- How Do Bisphosphonates Inhibit Bone Metastasis In Vivo
- (2015) Pierrick G. Fournier et al. NEOPLASIA
- Action of RANKL and OPG for Osteoclastogenesis
- (2012) Yasuhiro Kobayashi et al. CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION
- Contemporary Therapeutic Approaches Targeting Bone Complications in Prostate Cancer
- (2011) Richard J. Lee et al. Clinical Genitourinary Cancer
- Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study
- (2011) Karim Fizazi et al. LANCET
- Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2010) A. Horwich et al. ANNALS OF ONCOLOGY
- Efficacy of zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: 36-month results of the ZO-FAST Study
- (2010) H. Eidtmann et al. ANNALS OF ONCOLOGY
- Assessment of fracture risk in women with breast cancer using current vs emerging guidelines
- (2010) P Hadji et al. BRITISH JOURNAL OF CANCER
- Adjuvant aromatase inhibitor therapy: Outcomes and safety
- (2010) Wolfgang Janni et al. CANCER TREATMENT REVIEWS
- Effects of a Structured Weight-Bearing Exercise Program on Bone Metabolism Among Breast Cancer Survivors: A Feasibility Trial
- (2010) Luke J. Peppone et al. Clinical Breast Cancer
- Bisphosphonates and RANK ligand inhibitors for the treatment and prevention of metastatic bone disease
- (2010) H.L. Neville-Webbe et al. EUROPEAN JOURNAL OF CANCER
- Exposure to Oral Bisphosphonates and Risk of Esophageal Cancer
- (2010) Chris R. Cardwell et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Preclinical pharmacology of CGP 42′446, a new, potent, heterocyclic bisphosphonate compound
- (2010) Jonathan R. Green et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Prevention of Aromatase Inhibitor–Induced Bone Loss Using Risedronate: The SABRE Trial
- (2010) Catherine Van Poznak et al. JOURNAL OF CLINICAL ONCOLOGY
- Atrial Fibrillation and Stroke Associated With Intravenous Bisphosphonate Therapy in Older Patients With Cancer
- (2010) Gregg S. Wilkinson et al. JOURNAL OF CLINICAL ONCOLOGY
- Fracture Types and Risk Factors in Men With Prostate Cancer on Androgen Deprivation Therapy: A Matched Cohort Study of 19,079 Men
- (2010) Shabbir M.H. Alibhai et al. JOURNAL OF UROLOGY
- Bisphosphonates and Fractures of the Subtrochanteric or Diaphyseal Femur
- (2010) Dennis M. Black et al. NEW ENGLAND JOURNAL OF MEDICINE
- Teriparatide Therapy for Alendronate-Associated Osteonecrosis of the Jaw
- (2010) Ada Cheung et al. NEW ENGLAND JOURNAL OF MEDICINE
- A systematic review and meta-analysis of bone metabolism in prostate adenocarcinoma
- (2010) Ary Serpa Neto et al. BMC Urology
- Compliance and treatment satisfaction of post menopausal women treated for osteoporosis. Compliance with osteoporosis treatment
- (2010) Dominique Huas et al. BMC Womens Health
- An open-label, phase 2 trial of denosumab in the treatment of relapsed or plateau-phase multiple myeloma
- (2009) Ravi Vij et al. AMERICAN JOURNAL OF HEMATOLOGY
- The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network
- (2009) E. Terpos et al. ANNALS OF ONCOLOGY
- Effect of denosumab on bone mineral density in women receiving adjuvant aromatase inhibitors for non-metastatic breast cancer: subgroup analyses of a phase 3 study
- (2009) Georgiana K. Ellis et al. BREAST CANCER RESEARCH AND TREATMENT
- Bone density vs bone quality: What's a clinician to do?
- (2009) A. LICATA CLEVELAND CLINIC JOURNAL OF MEDICINE
- Zoledronic Acid Effectively Prevents Aromatase Inhibitor–Associated Bone Loss in Postmenopausal Women with Early Breast Cancer Receiving Adjuvant Letrozole: Z-FAST Study 36-Month Follow-up Results
- (2009) Adam M. Brufsky et al. Clinical Breast Cancer
- Demographic, Dietary, and Urinary Factors and 24-h Urinary Calcium Excretion
- (2009) E. N. Taylor et al. Clinical Journal of the American Society of Nephrology
- Expected long-term survival of patients diagnosed with multiple myeloma in 2006-2010
- (2009) H. Brenner et al. HAEMATOLOGICA
- Randomized Phase II Trial of Denosumab in Patients With Bone Metastases From Prostate Cancer, Breast Cancer, or Other Neoplasms After Intravenous Bisphosphonates
- (2009) Karim Fizazi et al. JOURNAL OF CLINICAL ONCOLOGY
- Effects of Denosumab on Bone Mineral Density in Men Receiving Androgen Deprivation Therapy for Prostate Cancer
- (2009) Matthew R. Smith et al. JOURNAL OF UROLOGY
- RANKL inhibition in the treatment of bone metastases
- (2009) Allan Lipton et al. Current Opinion in Supportive and Palliative Care
- Guidance for the management of breast cancer treatment-induced bone loss: A consensus position statement from a UK Expert Group
- (2008) David M. Reid et al. CANCER TREATMENT REVIEWS
- Prevention of Anastrozole-Induced Bone Loss with Monthly Oral Ibandronate during Adjuvant Aromatase Inhibitor Therapy for Breast Cancer
- (2008) J. E. Lester et al. CLINICAL CANCER RESEARCH
- Risedronate Prevents Bone Loss in Breast Cancer Survivors: A 2-Year, Randomized, Double-Blind, Placebo-Controlled Clinical Trial
- (2008) Susan L. Greenspan et al. JOURNAL OF CLINICAL ONCOLOGY
- Ten-Year Follow-Up of 3 Years of Oral Adjuvant Clodronate Therapy Shows Significant Prevention of Osteoporosis in Early-Stage Breast Cancer
- (2008) Tiina Saarto et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now